• Evolving from ‘My Data’ to ‘Our Data’: How a Global Data Environment Can Advance Population Health Research

    Bio-IT World | The life sciences community has long faced challenges around data management, data sharing, and the IT infrastructure needed to support scientific research. An increase in global collaboration underscores the need for a cultural shift to view data no longer as “my data” but “our data.”

    Oct 21, 2022
  • Evotec Releases SaaS Pan-Omic Data Analysis Platform

    Bio-IT World | At the Bio-IT World Conference & Expo Europe yesterday, Evotec SE launched the first commercial version of its PanOmics data analysis platform PanHunter. PanHunter is Evotec’s PanOmics data access and analytics platform and was developed and used successfully internally and in industry-shaping drug discovery partnerships over many years. Evotec now makes PanHunter available to collaborators and partners as a software-as-a-service (“SaaS”) product.

    Oct 20, 2022
  • MemVerge Memory Machine Takes Best of Show Award in Berlin

    Bio-IT World | Bio-IT World has announced the winner of the first Bio-IT World Europe Best of Show Awards. Among finalists from Dassault Systèmes BIOVIA, Evotec, The Hyve, Ontoforce, and Quilt Data, MemVerge was named the Best of Show People’s Choice winner.

    Oct 20, 2022
  • Building AI for the Drug Discovery Learning Problem

    Bio-IT World | At the Bio-IT World Conference and Expo Europe yesterday, Richard Law, chief business officer for Exscientia, kicked off the event with an AI reality check. The term AI barely means anything anymore, he said, but he’s not the least bit soured on the possibility. We just need to shift our expectations.

    Oct 19, 2022
  • Illumina Unveils New Fleet Of Sequencing Instruments

    Bio-IT World | The recent Illumina Genomics Forum occasioned the launch of several game-changing products, including the first FDA-regulated and CE-marked in vitro diagnostic high-throughput sequencer (NovaSeq 6000 Dx) and the company’s most powerful sequencer to date (NovaSeq X series) that can run 20,000 whole human genomes a year on a single instrument.

    Oct 18, 2022
  • With More Oncology Data at Our Fingertips, Interpretation Tools Are Key

    Bio-IT World | Oncology has been a shining example of the promise of precision medicine, and the tremendous gains to be made in human health when patients can be prescribed the right drug at the right time. But oncology has also shown the challenge of precision medicine: data interpretation. With each new source of data, the difficulty of making sense of the aggregated information only increases.

    Oct 14, 2022
  • Interactive Microbial Atlas Outlines Associations Between the Gut Microbiome and Plasma Metabolites

    Bio-IT World | A team of Swedish researchers from Uppsala and Lund Universities created the first large-scale microbial atlas, linking gut microbiota to specific metabolites and their potential health impact on humans.

    Oct 13, 2022
  • Bio-IT World Opens Call for 2023 Innovative Practices Awards Entries

    Bio-IT World | Bio-IT World is accepting entries for the 2023 Innovative Practices Awards competition. The deadline for entry is March 3, 2023, and the $300 application fee will be waived for entrants who meet the early deadline of January 6, 2023.

    Oct 11, 2022
  • Bio-IT World Best of Show Announces Finalists, Opens Judging

    Bio-IT World | Bio-IT World has announced the entries in our first Bio-IT World Europe Best of Show Awards. Entries from Dassault Systèmes BIOVIA, Evotec, The Hyve, MemVerge, Ontoforce, and Quilt Data are finalists for the Best of Show People’s Choice Award.

    Oct 10, 2022
  • Select European Research Institutes Become the First to Join International Data Network

    Bio-IT World | Research institutes representing five western European countries—Finland, Germany, Norway, Spain, and Sweden—will become the first to join the Federated European Genome-phenome Archive, an international distributed data network designed to share highly-sensitive human ’omics data internationally.

    Oct 6, 2022
  • Wearable Sensor Continuously Measures Subcutaneous Tumor Progression and Regression

    Bio-IT World | A team of researchers from Stanford University and the Georgia Institute of Technology designed a malleable, battery-operated wearable sensor that continuously monitors subcutaneous tumor progression, regression, and treatment efficacy.

    Oct 4, 2022
  • New 30-Plex Immuno-Oncology Protein Target Panel, Temple Medicine’s Pulmonary Artery Blood Clot Reduction Device, More

    Bio-IT World | A cloud-based software solution to streamline flow cytometry workflow; the world’s most extensive repeated set of highly-detailed, multi-organ images from a large cohort of participants; a gene editing therapy for inflammatory cardiac diseases; and more.

    Sep 29, 2022
  • Follow the Money: NIH Funds Brain Mapping Network Initiative, Non-Invasive Skin Patch for Vaccine Delivery, More

    Bio-IT World | Funding for multi-omic human brain cell atlas, AI-based drug discovery and development, genomic medicine software simulation platform, and more.

    Sep 28, 2022
  • PacBio Announces New Analysis Method for Tandem Repeats

    Bio-IT World | PacBio has announced the availability of a new computational analysis method for profiling more than a million tandem repeats across the human genome using PacBio’s native long-read HiFi sequencing data. The Tandem Repeat Genotyping Tool is intended to provide scientists with the ability to obtain a full characterization of the sequence and methylation status of tandem repeats genome-wide.

    Sep 27, 2022
  • State of the Industry: Checking in on AI Trends and Progress with Fernanda Foertter

    Bio-IT World | In the latest episode of Bio-IT World’s Trends from the Trenches podcast, host Stan Gloss, founder of BioTeam, gets an update from Fernanda Foertter, Voltron Data, about her AI experiences in the past few years and whether we’ve made any real progress.

    Sep 27, 2022
  • Lessons From the Recent HCA 2022 General Meeting: Applying Single-Cell Data to Clinical Decision Making

    Bio-IT World | Since mid-2021, many papers have described actionable links between genome-wide association studies and specific diseases based on single-cell data. But one associated challenge that comes up repeatedly is the handling, storing, and analyzing of the abundant data that is now available.

    Sep 23, 2022
  • NVIDIA Announces Plans to Expand Large Language Models for Biology

    Bio-IT World | At NVIDIA’s annual GTC event two days ago, the company made two particular announcements key to the life sciences space. First, NVIDIA announced it will make Clara Parabricks available on the Broad Institute’s Terra cloud platform. Second, the company revealed plans to expand large language models to biology, announcing BioNeMo.

    Sep 22, 2022
  • Berlin Agenda: Our Plans for the Bio-IT World Conference & Expo Europe

    Bio-IT World | Bio-IT World is heading to Berlin next month to explore biotech advancements happening in Europe. With five conference tracks, a plenary program, and an exhibit hall we are making the most of the packed two days of scientific content and industry best practices. Here are just a few of the presentations and themes flagged thus far.

    Sep 21, 2022
  • Glioblastoma Cancer Cells ‘Starve’ Without Astrocyte Immunometabolic Support

    Bio-IT World | Tel Aviv University researchers discovered that glioblastoma cells—a highly resistant, aggressive, and deadly form of cancer—“starve” to death without immunometabolic support from astrocytes.

    Sep 20, 2022
  • Mount Sinai Aims To Enroll One Million People In Genetic Sequencing Project

    Bio-IT World | The greater New York metropolitan area is the epicenter of an ambitious human genome sequencing research project newly launched by Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai. If the vision is realized, Mount Sinai will enroll a million patients into a study over the next five years that will sequence and analyze the DNA in their blood to tease out the role of genetics and environment on health.

    Sep 15, 2022